Navigation Links
FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
Date:7/8/2009

WOODCLIFF LAKE, N.J., July 8 /PRNewswire/ -- Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for an alternative five-day dosing regimen for Dacogen(R) (decitabine for injection) to treat patients with myelodysplastic syndromes (MDS). MDS is a potentially life-threatening group of bone marrow diseases that limit the production of functional blood cells.

Currently, Dacogen is approved for use as a three-day regimen, administered at a dose of 15 mg/m2 via continuous IV infusion over three hours repeated every eight hours for three consecutive days per cycle. The cycle is repeated every six weeks. The alternative five-day dosing regimen of Dacogen(R) submitted to the U.S. FDA is a single daily dose with a significantly reduced administration time. If approved, patients with MDS may experience increased convenience with the new dosing regimen.

"We're pleased that the FDA has agreed to review our application for the alternative dosing regimen, and we look forward to working with the agency throughout the review process," said Cynthia Schwalm, President of Eisai Inc. "This application is one part of a full complement of clinical development programs we have committed for Dacogen and is a vital part of our human health care mission of increasing patient benefits and fulfilling unmet medical needs."

Acceptance of the sNDA means that FDA has found the company's submission to be sufficiently complete to review.

About Dacogen

The safety profile of decitabine for injection is well characterized. Dacogen (decitabine for injection) was approved by the FDA on May 2, 2006, and is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-Ameri
'/>"/>

SOURCE Eisai Corporation of North America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
2. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
3. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
4. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
5. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
6. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
7. New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients
8. Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
9. Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
10. Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives
11. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., BOTHELL, Wash., Nov. 6 ...inancial results for the three and nine months end...SCOLR Pharma,s President and CEO, said, "We contin... 12-hour ibuprofen formulation. Several potential ...ime, personnel and external resources as they eval...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 Trius Therapeu...istration statement on Form S-1 with the U.S. Secu... proposed initial public offering of shares of its...e sold in the offering will be offered by the Comp...cting as sole book-running manager, Piper Jaffray ...
(Date:11/6/2009)..., DETROIT, Nov. 6 Caraco...D ) has launched ketorolac tromethamine ophthalmic...e US Food and Drug Administration (FDA) for Sun Ph... generic Acular® ophthalmic solution on the f...h of ketorolac is therapeutically equivalent to Ac...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco 47852 1LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco 47852 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 1U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 3InterMune to Present at Goldman Sachs Healthcare Conference 12456 1
...BUSINESS WIRE)-May 10, 2007--Today, the,New Englan...wo,Phase III studies of Merck,s cervical cancer va... (Types 6, 11, 16, 18),Recombinant Vaccine). In th...ction against cervical, vaginal and vulvar disease...d to protect,against, HPV types 6, 11, 16, and 18....
...May 11, 2007 /PRNewswire-FirstCall/ --,NicOx S.A. ...ase 2a,study for NCX 1000, which is covered by its... preliminary analysis of 11 patients,from this pro...ed,the safety profile of NCX 1000 but did not demo...nuation of this clinical trial. As a,consequence, ...
Other Medicine Technology:New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 2New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 3New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 5New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 6New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 7New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 8New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 9New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 10New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 11New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 12New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 13New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 14New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 15New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 16New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 17New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 18New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 19New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 20New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 21New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 22New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 23New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 24New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 25New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 26New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 27New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 28New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 29New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 30New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 31New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 32NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3
(Date:11/6/2009)... U.S. Department of Veterans Affairs held a histor... signal the beginning of a new mission for the age..., More than 1,300 VA clinicians and health care sp...ested in providing support for homeless and low-in...ice providers represented by the National Coalitio...
(Date:11/6/2009)...lan International, a leading children,s developmen... the world, has been asked to deliver eight presen... upcoming American Public Health Association,s (AP...a, Pennsylvania on November 7-11, 2009. ,, The Am...ions together to address current and emerging heal...
(Date:11/6/2009)... A survey released today from Jackson Healthcare ...74 percent) feel they have less control over the w... ago. , Alpharetta, GA (V...from Jackson Healthcare reports that the majorit...ve less control over the way they practice medicin...
(Date:11/6/2009)...em to wane as years go by, researcher says , ...ch suggests that people with multiple sclerosis wh...e disease are more likely to suffer from severe li...ondition. , The findings, published Nov. 4 in Neu...apse within five years of developing it are nearly...
(Date:11/6/2009)... School nurses mistakenly inject three public sch...alpractice lawyers, including David Perceman, are ...re not being reported. , ...oss New York, medical malpractice lawyers are un... flu vaccine by public school nurses without a med...
Breaking Medicine News(10 mins):Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News:Plan's Expertise Highlighted at Premier Health Forum 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 3
...ous studies on rats prove experiencing control ove...stressors which they cannot face without developin...National Institute of Mental Health (NIMH) have un...he brain's executive hub, the prefrontal cortex, b...
...: Christmas cookies and cakes are loaded with calo...r dish is rich in calories,// we still go ahead an...a calories actually get accumulated. Worse still, ...oner, has enabled a true account of the amount of ...
...te health care is set to boom following expectatio...in six years. // The four per cent increase equ...al family rebated premium of $1,750, will begin in... Health Minister Tony Abbott is putting pressure o...
...terium called Salmonella enteriditis (SE) is prese... from these eggs( without being properly cooked) a...od and Drug Administration) warns consumers to be ...gnog, and some types of stuffing, contain eggs tha...
...ar disorder is a mental disorder known to have a g...es Watson, who was a codiscoverer of DNA double he...by Researchers fom The Zucker Hillside Hospital ca...plex illnesses like bipolar disorder that vary dra...
...el strategy to combat malaria is abuzz, and the ma... infect mosquitoes. // The researchers from t...h a vaccine that when tested on mice, instigated t...s into the mosquito’s body, through the bite. The ...
Other Medicine News:Health News:Prior Experience to Stress Acts as an Immunization 2Health News:Research on Bipolar Disorder Launched 2
Lancaster Eye Speculum
McPherson Speculum
Guyton-Park Speculum
Snare Wire Replacements for E3525 3/package
Medicine Products: